Evogene Market Cap

Evogene has a market cap or net worth of 20.69 million as of March 9, 2026. Its market cap has decreased by -42.41% in one year.

Market Cap

20.69M

Enterprise Value

24.73M

Revenue

26.54M

Ranking

n/a

PE Ratio

n/a

Stock Price

237.30

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from 78.38M to 20.69M, a decrease of -73.60%. That is a compound annual growth rate of -6.98%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	21.42M	-18.25%
Dec 31, 2025	26.20M	-44.67%
Dec 31, 2024	47.35M	-68.75%
Dec 31, 2023	151.55M	64.52%
Dec 29, 2022	92.12M	-58.37%
Dec 30, 2021	221.26M	-59.72%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
XTL Biopharmaceuticals	19.87M
Can-Fite BioPharma	19.70M
Purple Biotech	18.58M
BioLight Life Sciences	31.31M
BioLineRx	39.16M
Clal Biotechnology Industries	46.43M
Matricelf	146.87M
Geffen Residence & Renewal	277.04M

Market Cap Rankings